Literature DB >> 13134

Cholic acid biosynthesis: conversion of 5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol into 5beta-cholestane-3alpha,7alpha, 12alpha,24beta,25-pentol by human and rat liver microsomes.

F W Cheng, S Shefer, B Dayal, G S Tint, T Setoguchi, G Salen, E H Mosbach.   

Abstract

This paper describes the conversion of 5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol into 5beta-cholestane-3alpha,7alpha,12alpha,24beta,25-pentol by liver microsomes. A sensitive radioactive assay for measuring the formation of 5beta-cholestane-3alpha,7alpha,12alpha,24beta,25-pentol was developed. Optimal assay conditions for human and rat microsomal systems were established. A higher 24beta-hydroxylation activity was detected in rat than in human liver under the conditions employed. The hydroxylation of 5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol by the rat liver microsomal fraction fortified with NADPH was stimulated about two-fold by administration of phenobarbital. Phenobarbital treatment also stimulated hydroxylations at C-23, C-24alpha, and C-26. Carbon monoxide markedly inhibited all side-chain hydroxylations. In contrast, side-chain hydroxylase activities were not affected in animals deprived of food for 48 hr. These results are consistent with a previously postulated cholic acid biosynthetic pathway involving 5beta-cholestane-3alpha,7alpha,12alpha,24beta,25-pentol as a key intermediate in man and in the rat.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 13134

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  3 in total

1.  Biosynthesis of chenodeoxycholic acid in man: stereospecific side-chain hydroxylations of 5beta-cholestane-3alpha,7alpha-diol.

Authors:  S Shefer; F W Cheng; A K Batta; B Dayal; G S Tint; G Salen
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

2.  Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.

Authors:  G Salen; S Shefer; F W Cheng; B Dayal; A K Batta; G S Tint
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

Review 3.  [Atypical bile acids (author's transl)].

Authors:  P Back
Journal:  Klin Wochenschr       Date:  1980-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.